Hypermethylation leads to bone morphogenetic protein 6 downregulation in hepatocellular carcinoma.
BACKGROUND: In the liver, bone morphogenetic protein 6 (BMP-6) maintains balanced iron metabolism. However, the mechanism that underlies greater BMP-6 expression in hepatocellular carcinoma (HCC) tissue than adjacent non-cancerous tissue is unclear. This study sought to investigate the epigenetic me...
Main Authors: | Yinghua He, Ying Cui, Baiying Xu, Jun Gu, Wei Wang, Xiaoying Luo |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3907571?pdf=render |
Similar Items
-
SIP1 is downregulated in hepatocellular carcinoma by promoter hypermethylation
by: Oztas Emin, et al.
Published: (2011-06-01) -
Promoter hypermethylation mediated downregulation of FBP1 in human hepatocellular carcinoma and colon cancer.
by: Mingquan Chen, et al.
Published: (2011-01-01) -
Identification of RASSF1A promoter hypermethylation as a biomarker for hepatocellular carcinoma
by: Gang Xu, et al.
Published: (2020-11-01) -
The Silencing of RECK Gene is Associated with Promoter Hypermethylation and Poor Survival in Hepatocellular Carcinoma
by: Changsong Zhang, Yang Ling, Chenghui Zhang, Yun Xu, Lu Gao, Rong Li, Jing Zhu, Lieying Fan, Lixin Wei
Published: (2012-01-01) -
Hypermethylation of the PZP gene is associated with hepatocellular carcinoma cell proliferation, invasion and migration
by: Minhua Wu, et al.
Published: (2021-03-01)